112 related articles for article (PubMed ID: 28260213)
21. Thromboembolic disease and testicular germ cell tumors.
Miskovska V; Ondrus D
Bratisl Lek Listy; 2010; 111(3):166-7. PubMed ID: 20437830
[TBL] [Abstract][Full Text] [Related]
22. Current chemotherapeutic approaches for recurrent or refractory germ cell tumors.
O'Carrigan B; Grimison P
Urol Oncol; 2015 Aug; 33(8):343-54. PubMed ID: 25308563
[TBL] [Abstract][Full Text] [Related]
23. Biology and genetics of adult male germ cell tumors.
Houldsworth J; Korkola JE; Bosl GJ; Chaganti RS
J Clin Oncol; 2006 Dec; 24(35):5512-8. PubMed ID: 17158536
[TBL] [Abstract][Full Text] [Related]
24. Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature.
Meattini I; Scotti V; Pescini F; Livi L; Sulprizio S; Palumbo V; Sarti C; Biti G
J Chemother; 2010 Apr; 22(2):134-6. PubMed ID: 20435575
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of everolimus in refractory testicular germ cell tumors.
Mego M; Svetlovska D; Miskovska V; Obertova J; Palacka P; Rajec J; Sycova-Mila Z; Chovanec M; Rejlekova K; Zuzák P; Ondrus D; Spanik S; Reckova M; Mardiak J
Urol Oncol; 2016 Mar; 34(3):122.e17-22. PubMed ID: 26612480
[TBL] [Abstract][Full Text] [Related]
26. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors.
Nguyen CT; Stephenson AJ
Hematol Oncol Clin North Am; 2011 Jun; 25(3):593-604, ix. PubMed ID: 21570611
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy and chemotherapy in testis tumors.
Scalliet P; Van Oosterom AT
J Belge Radiol; 1993 Mar; 76(2):93-7. PubMed ID: 8395499
[TBL] [Abstract][Full Text] [Related]
28. Current Management of Refractory Germ Cell Tumors and Future Directions.
Allen JC; Kirschner A; Scarpato KR; Morgans AK
Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447
[TBL] [Abstract][Full Text] [Related]
29. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
[TBL] [Abstract][Full Text] [Related]
30. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.
Olasz J; Mándoky L; Géczi L; Bodrogi I; Csuka O; Bak M
Anticancer Res; 2005; 25(6B):4319-24. PubMed ID: 16309235
[TBL] [Abstract][Full Text] [Related]
31. Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors.
Kirch C; Blot F; Fizazi K; Raynard B; Theodore C; Nitenberg G
Support Care Cancer; 2003 Sep; 11(9):575-80. PubMed ID: 12783290
[TBL] [Abstract][Full Text] [Related]
32. First-line chemotherapy of disseminated germ cell tumors.
Nichols C; Kollmannsberger C
Hematol Oncol Clin North Am; 2011 Jun; 25(3):543-56, viii. PubMed ID: 21570608
[TBL] [Abstract][Full Text] [Related]
33. Curing metastatic cancer: lessons from testicular germ-cell tumours.
Masters JR; Köberle B
Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
[TBL] [Abstract][Full Text] [Related]
34. Testicular seminoma occurring 8 years after treatment of a metastatic extragonadal germ cell tumor.
Ando R; Yasui T; Tozawa K; Sasaki S; Hayashi Y; Kohri K
Int J Urol; 2007 Jan; 14(1):85-6. PubMed ID: 17199868
[TBL] [Abstract][Full Text] [Related]
35. Postchemotherapy surgery for germ cell tumors of the testis.
Carver BS; Sheinfeld J
Curr Opin Oncol; 2011 May; 23(3):271-4. PubMed ID: 21415749
[TBL] [Abstract][Full Text] [Related]
36. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
Gilbert DC; Norman AR; Nicholl J; Dearnaley DP; Horwich A; Huddart RA
BJU Int; 2006 Jul; 98(1):67-9. PubMed ID: 16831145
[TBL] [Abstract][Full Text] [Related]
37. A phase I-II trial of intensive chemotherapy (CT) with autologous bone-marrow transplantation (ABMT) in metastatic malignant germ cell tumors of the testis (NSGCTT).
Droz JP; Pico JL; Hayat M; Kamioner D; Gouyette A; Beaujean F
Prog Clin Biol Res; 1985; 203():449-50. PubMed ID: 3008182
[No Abstract] [Full Text] [Related]
38. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.
Honecker F; Wermann H; Mayer F; Gillis AJ; Stoop H; van Gurp RJ; Oechsle K; Steyerberg E; Hartmann JT; Dinjens WN; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Clin Oncol; 2009 May; 27(13):2129-36. PubMed ID: 19289622
[TBL] [Abstract][Full Text] [Related]
39. Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.
Bosl GJ; Geller NL; Vogelzang NJ; Carey R; Auman J; Whitmore WF; Herr H; Morse M; Sogani P; Chan E
J Clin Oncol; 1987 Mar; 5(3):436-40. PubMed ID: 2434627
[TBL] [Abstract][Full Text] [Related]
40. The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?
Necchi A; Nicolai N; Giannatempo P; Raggi D; Miceli R; Mariani L; Salvioni R
Clin Genitourin Cancer; 2016 Feb; 14(1):1-4. PubMed ID: 26329776
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
